Item(by='kenhwang', descendants=None, kids=[25579731, 25579667, 25580120, 25580227, 25580845, 25581547, 25579612], score=None, time=1609315108, title=None, item_type='comment', url=None, parent=25579393, text='Looks like they approved the two-dose 62% ~effective~ efficacy  regiment.<p>There was a lot of hope for the one-dose given the supply constraints or a retrial for the more promising half+full dose for greater efficacy.<p>I wonder if people will ask which vaccine they&#x27;re receiving. 62% is kinda underwhelming when there&#x27;s two 95% ones (Pfizer&#x2F;Moderna), a 92% one (Gamaleya), and a 79-86% one (Sinopharm). With the latter two also not needing subzero temps.')